CalciMedica Inc

Research CalciMedica Inc (CALC) on Bullrun: market cap USD 15.59M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCALC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 15.59M
• Financial periodFY2025
• Net income-USD 29.56M
• Free cash flow-USD 21.21M

Valuation Snapshot

latest market cap is USD 15.59M.

About CalciMedica Inc

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.

Frequently asked questions

What is CalciMedica Inc's market cap?

CalciMedica Inc's market capitalization is USD 15.59M.

What does CalciMedica Inc do?

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.